RELAY THERAPEUTICS INC. - COMMON STOCK

Relay Therapeutics Discloses Anticipated Registrational Path for RLY-4008 in Cholangiocarcinoma and Growing Breast Cancer Franchise at Virtual Analyst and Investor Event

27 июн 2022 06:00:00 Источник Nasdaq GlobeNewswire

Relay Therapeutics Announces Timing of Virtual Analyst and Investor Event

16 июн 2022 07:30:00 Источник Nasdaq GlobeNewswire

Relay Therapeutics to Participate in Two Upcoming Investor Conferences

26 май 2022 07:30:00 Источник Nasdaq GlobeNewswire

Relay Therapeutics Reports First Quarter 2022 Financial Results and Corporate Highlights

05 май 2022 16:05:00 Источник Nasdaq GlobeNewswire

Relay Therapeutics to Participate in Fireside Chat at Bank of America Securities 2022 Healthcare Conference

03 май 2022 07:30:00 Источник Nasdaq GlobeNewswire

Relay Therapeutics to Announce First Quarter 2022 Financial Results and Corporate Highlights

28 апр 2022 16:05:01 Источник Nasdaq GlobeNewswire

Relay Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate Highlights

24 фев 2022 16:05:01 Источник Nasdaq GlobeNewswire

Relay Therapeutics to Announce Fourth Quarter and Full Year 2021 Financial Results and Corporate Highlights

17 фев 2022 16:05:00 Источник Nasdaq GlobeNewswire

Relay Therapeutics to Participate in Two Upcoming Investor Conferences

02 фев 2022 07:30:00 Источник Nasdaq GlobeNewswire

Relay Therapeutics Announces Dosing of First Patient in First-in-Human Trial of RLY-2608 and Initiation of Expansion Cohorts for First-In-Human Trial of RLY-4008

04 янв 2022 07:30:00 Источник Nasdaq GlobeNewswire

Relay Therapeutics to Present at 40th Annual J.P. Morgan Healthcare Conference

03 янв 2022 07:30:00 Источник Nasdaq GlobeNewswire

Relay Therapeutics Announces Preclinical Data that Support Clinical Development of RLY-2608 as Both a Single Agent and in Combination

10 дек 2021 07:30:00 Источник Nasdaq GlobeNewswire

Relay Therapeutics Reports Third Quarter 2021 Financial Results and Recent Corporate Highlights

10 ноя 2021 16:05:01 Источник Nasdaq GlobeNewswire

Relay Therapeutics to Announce Third Quarter 2021 Financial Results and Recent Corporate Highlights

04 ноя 2021 16:05:02 Источник Nasdaq GlobeNewswire

Relay Therapeutics Announces Pricing of Public Offering of Common Stock

12 окт 2021 21:58:23 Источник Nasdaq GlobeNewswire

Relay Therapeutics Announces Proposed Public Offering of Common Stock

11 окт 2021 16:15:00 Источник Nasdaq GlobeNewswire

Relay Therapeutics Announces Interim Clinical Data that Support RLY-4008 as a Highly Selective FGFR2 Inhibitor

08 окт 2021 06:00:00 Источник Nasdaq GlobeNewswire

Relay Therapeutics Announces Preclinical Data that Support RLY-2608 as the First Known Allosteric Pan-Mutant Selective Inhibitor of PI3Kα

07 окт 2021 08:50:00 Источник Nasdaq GlobeNewswire

Relay Therapeutics to Present Clinical Data on RLY-4008 and Preclinical Data on RLY-2608 at AACR-NCI-EORTC Molecular Targets Conference

13 сен 2021 06:00:00 Источник Nasdaq GlobeNewswire

Relay Therapeutics Announces Corporate Updates and Reports Second Quarter 2021 Financial Results

12 авг 2021 16:05:03 Источник Nasdaq GlobeNewswire